We are live on ! Find out more
CDMO

Avid Bioservices, Inc. Common Stock

Delisted

CDMO was delisted on the 4th of February, 2025.

172 hedge funds and large institutions have $1.35B invested in Avid Bioservices, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 53 increasing their positions, 58 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 17

56% more capital invested

Capital invested by funds: $869M → $1.35B (+$483M)

20% more funds holding in top 10

Funds holding in top 10: 56 (+1)

9% more funds holding

Funds holding: 158172 (+14)

9% less repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 58

40% less call options, than puts

Call options by funds: $2.69M | Put options by funds: $4.47M

Holders
172
Holders Change
+14
Holders Change %
+8.86%
% of All Funds
2.99%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.1%
New
31
Increased
53
Reduced
58
Closed
17
Calls
$2.69M
Puts
$4.47M
Net Calls
-$1.78M
Net Calls Change
-$4.59M

CDMO Hedge Fund Activity: Q2 2021 in Review

172 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q2 2021, worth a combined $1.35B — up 56% from $869M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new CDMO positions and 17 closed out — a net gain of 14 holders — while 53 added to existing stakes and 58 trimmed.

The largest buyer was State Street, adding an estimated $32.9M. The largest seller was Snyder Capital Management, cutting an estimated $8.38M.

  • 172 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q2 2021, up from 158 in Q1 2021.
  • Funds reported $1.35B of Avid Bioservices, Inc. Common Stock stock for Q2 2021, up 56% quarter-over-quarter.
  • 31 funds opened new Avid Bioservices, Inc. Common Stock positions in Q2 2021 and 17 closed out, a net change of +14 holders.
  • The largest Avid Bioservices, Inc. Common Stock buyer in Q2 2021 was State Street, an estimated $32.9M added.
  • The largest Avid Bioservices, Inc. Common Stock seller in Q2 2021 was Snyder Capital Management, an estimated $8.38M sold.

Based on aggregated 13F filings for Q2 2021.